SynthesisBMC pharmacology & toxicology2024

The efficacy and safety of belzutifan inhibitor in patients with advanced or metastatic clear cell renal cell carcinoma: a meta-analysis.

Ge Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.